# A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment

> **NCT04919499** · PHASE1,PHASE2 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 46 (actual)

## Conditions studied

- Diabetic Retinopathy

## Interventions

- **DRUG:** BI 765128
- **OTHER:** Sham comparator

## Key facts

- **NCT ID:** NCT04919499
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-30
- **Primary completion:** 2023-08-07
- **Final completion:** 2023-08-07
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2024-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04919499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04919499, "A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04919499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*